Catecholaminergic Polymorphic Ventricular Tachycardia in Children: An Analysis of Therapeutic Strategies and Outcomes from an International Multicenter Registry

摘要

BackgroundCatecholaminergic polymorphic ventricular tachycardia (CPVT) is an uncommon, potentially lethal, ion channelopathy. Standard therapies have high failure rates and little is known about treatment in children. Newer options such as flecainide and left cardiac sympathetic denervation (LCSD) are not well validated. We sought to define treatment outcomes in children with CPVT.